George Siber

George Siber is a Canadian-American medical researcher and vaccinologist.

He is known for developing vaccines, therapeutic antibodies, and diagnostic agents for infectious diseases.

Siber is a former Harvard professor, current adjunct professor at Johns Hopkins University and former professor at the University of Massachusetts Medical School.

Biography Siber emigrated from Bavaria, Germany, with his parents at age nine in 1953 to Montreal.

After high school, he attended Bishop's University in Lennoxville, Quebec from 1962 to 1966, where he graduated with honors and obtained a Bachelor of Science.

After graduation in 1970, Siber held several internships, residencies, and fellowships. Between 1970 and 1972, Siber worked in Chicago as an intern and junior medical resident at Rush University Medical Center. In 1972, Siber moved to Boston and worked as a senior medical resident and clinical fellow in medicine at Beth Israel Hospital until 1973. Between 1974 and 1975, Siber completed a fellowship in Infectious Diseases at Boston Children’s Hospital and Beth Israel Hospital.

Siber served as the vice president, chief scientific officer, and senior vice president, and executive vice president for Wyeth from 1996 to 2006. After retiring from Wyeth, Siber served on the Board of Directors and Scientific Advisory Boards of multiple vaccine companies. on the board of directors.

Siber was appointed to the board of trustees of the International Vaccine Institute in Korea in 2014 and chaired

Siber holds patents on RespiGam, the first Human respiratory syncytial virus immune globulin, and Prevnar, the first Pneumococcal Pneumonia Conjugate.

Respigam was the first antibody licensed for preventing severe RSV infections in high-risk infants and was the precursor product to Synagis, the first human monoclonal antibody for infectious diseases. Prevnar 7 and 13 are for the prevention of pneumococcal infections, the most common and severe bacterial infection of children and elderly adults worldwide causing mortality exceeding 1 million per year. Prevnar is also the most successful commercial vaccine of all time with sales exceeding four billion dollars per year.

Siber developed Meningitec (sp),

Awards 1962-1966 – Domtar Scholar, Bishop's University, Lennoxville, Quebec, Canada 1966-1970 – University Scholar, McGill University, Montreal, Quebec, Canada 1968–present – Alpha Omega Alpha 1970 – Holmes Gold Medal, McGill University, Montreal, Quebec, Canada 1970 – J. Francis Williams Scholarship in Clinical Medicine, McGill University, Montreal, Quebec, Canada 1971 – Rush Medical College Award, Rush-Presbyterian-St. Luke's Hospital, Chicago, Illinois (Best Medical Intern) 1972 – Department of Medicine Award, Rush-Presbyterian-St. Luke's Hospital, Chicago, Illinois (Best Medical Resident) 1975 – Canadian MRC Fellowship in Infectious Diseases 2008 – Dedication of Massachusetts Biologic Laboratories Research and Development Building, Mattapan, MA to George R. Siber and Jeanne Leszczynsky 2016 – Albert B. Sabin Gold Medal 2024-DCL, Bishop’s University